Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins

PURPOSE: To evaluate cervical mucus secretory leukocyte protease inhibitor (SLPI) concentrations in patients with high-risk human papillomavirus (hrHPV) 16 or 18 positive and low-grade squamous intraepithelial lesions (LGSIL) or high-grade squamous intraepithelial lesions (HGSIL). METHOD: Patients w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Control
Autores principales: Sahin, Erdem, Madendag, Yusuf, Sahin, Mefkure Eraslan, Madendag, Ilknur Col, Acmaz, Gokhan, Karakukcu, Cıgdem, Karaman, Hatice, Muderris, Iptisam Ipek
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125859/
https://ncbi.nlm.nih.gov/pubmed/30180755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274818798598
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares